Search

everythinglearnresearchcommunity

for

Search:↓

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

NK cells play a role in skin diseases like eczema and psoriasis.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Alopecia Areata might be linked to Crohn's disease.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Apremilast did not work for treating severe alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Abrocitinib may effectively treat stubborn alopecia universalis.